Pharmabiz

New UK-Singapore partnership to accelerate healthcare innovations

New UK-Singapore partnership to accelerate healthcare innovations: United Kingdom Saturday, October 10, 2026, 17:00 Hrs [IST] The NIHR and the National Health Innovation Centre Si ...
Pharmabiz

Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer

Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer: Lexington, Massachusetts Saturday, October ...
Pharmabiz

BNCP student Sampada Desai brings global recognition to India in Chemical Lab Tech at “48th WorldSkills Shanghai 2026”

Mumbai, celebrates the outstanding achievement of Sampada Desai, final-year B.Pharm student of BNCP, who was awarded the ...
Pharmabiz

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies: Shardul Nautiyal, Mumbai ...
Pharmabiz

Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer

Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer: San Francisco Saturday, October 10, 2026, 15:00 Hrs [IST] Vir ...
Pharmabiz

Newron Pharma updates on US FDA clinical trial hold and phase 3 ENIGMA-TRS development programme

Newron Pharma updates on US FDA clinical trial hold and phase 3 ENIGMA-TRS development programme: Milan, Italy Saturday, October 10, 2026, 14:00 Hrs [IST] Newron Pharmaceuticals S ...
Pharmabiz

bioAffinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early

Affinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early: San Antonio Saturday, October 10, 2026, 13:00 Hrs [IST] bioAffinity Technologie ...
Pharmabiz

US FDA approves Roche’s Tecentriq in combo with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer

US FDA approves Roche’s Tecentriq in combo with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer: Basel Saturday, Octobe ...
Pharmabiz

Scholar Rock resubmits marketing authorisation application for apitegromab with EMA to treat children and adults with spinal muscular atrophy

Scholar Rock resubmits marketing authorisation application for apitegromab with EMA to treat children and adults with spinal muscular atrophy: Cambridge, Massachusetts Saturday, O ...
Opinion
PharmabizOpinion

Maarga Mind Care sees mental well-being as a national development priority

Maarga Mind Care sees mental well-being as a national development priority: Our Bureau, Bengaluru Saturday, October 10, 2026, 09:00 Hrs [IST] Maarga Mind Care views mental well-be ...
Opinion
PharmabizOpinion

Indian needs to reduce its import dependence on pharma-adjacent chemical inputs: Raghunath Kelkar

Indian needs to reduce its import dependence on pharma-adjacent chemical inputs: Raghunath Kelkar: Nandita Vijayasimha, Bengaluru Saturday, October 10, 2026, 08:00 Hrs [IST] India ...
Opinion
PharmabizOpinion

TMR on non-scheduled anti-cancer drugs may not make drugs affordable: Experts

TMR on non-scheduled anti-cancer drugs may not make drugs affordable: Experts: Gireesh Babu, New Delhi Saturday, October 10, 2026, 08:00 Hrs [IST] The central government's move to ...